I.M. Injections

There is a change in preferred IM injection sites to no longer use the dorsogluteal site. 

This poster is on the door of the medicaiton room in North Charleston. I wanted to place a picture on the blog for reference. 

Key Points:

¢  The dorsogluteal IM injection site will be removed as a medication administration option from McKesson and EPIC EMRs. 

¢  In accordance with evidence-based practice guidelines, the dorsogluteal site is not          recommended for intramuscular (IM) injection in the pediatric and adult patient populations.

¢      Rationale: The dorsogluteal site is associated with the following:

         ¢      Sciatic nerve injury

         ¢      Muscle fibrosis

         ¢      Unnecessary pain

         ¢      Inadvertent subcutaneous administration

         ¢      Weakened or amplified medication effects due to increased or decreased absorption

How will this affect your practice?

¢  Clinicians should no longer use the dorsogluteal site for administering IM injections as             recommended by evidence based practice guidelines.